Richard N. Kender

Insider Reports History

Location
C/O Merck & Co., Inc., One Merck Drive, Ws2 A 40, Whitehouse Station, NJ
Signature
/s/ Paul Lehr, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard N. Kender:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BICYCLE THERAPEUTICS PLC Director Ordinary Shares 23K $571K $24.82 Jan 2, 2025 Direct
Longeveron Inc. Director Class A Common Stock 33K $44.2K $1.34 Jul 15, 2025 Direct
Seres Therapeutics, Inc. Director Stock Option (right to buy) 100K Apr 10, 2025 Direct
Omega Therapeutics, Inc. Director Stock Option (Right to Buy) 50K Jun 20, 2024 Direct
BICYCLE THERAPEUTICS PLC Director Stock Option (right to buy) 12.5K Jan 2, 2025 Direct

Insider Reports Filed by Richard N. Kender

Symbol Company Period Transactions Value $ Form Type Date Filed Role
LGVN Longeveron Inc. Jul 15, 2025 1 $0 4 Jul 17, 2025 Director
MCRB Seres Therapeutics, Inc. Apr 10, 2025 1 $0 4 Apr 11, 2025 Director
BCYC BICYCLE THERAPEUTICS PLC Jan 2, 2025 2 $0 4 Jan 6, 2025 Director
OMGA Omega Therapeutics, Inc. Jun 20, 2024 1 $0 4 Jun 21, 2024 Director
OMGA Omega Therapeutics, Inc. Jun 20, 2024 0 $0 3 Jun 21, 2024 Director
LGVN Longeveron Inc. May 10, 2024 1 $23.3K 4 May 14, 2024 Director
LGVN Longeveron Inc. May 10, 2024 0 $0 3 May 14, 2024 Director
MCRB Seres Therapeutics, Inc. Apr 4, 2024 1 $0 4 Apr 8, 2024 Director
BCYC BICYCLE THERAPEUTICS plc Jan 2, 2024 2 $0 4 Jan 4, 2024 Director
MCRB Seres Therapeutics, Inc. Jun 22, 2023 1 $0 4 Jun 23, 2023 Director
BCYC BICYCLE THERAPEUTICS plc Jan 3, 2023 2 $0 4 Jan 5, 2023 Director
MCRB Seres Therapeutics, Inc. Jul 5, 2022 1 $200K 4 Jul 6, 2022 Director
MCRB Seres Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
MCRB Seres Therapeutics, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
BCYC BICYCLE THERAPEUTICS plc Jan 3, 2022 2 $0 4 Jan 5, 2022 Director
MCRB Seres Therapeutics, Inc. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director